Tag: Prescription Drugs
New Drug Effectively Lowers Levels of Triglycerides
But it's not yet ready for standard care
New Rx for Myeloid Malignancies Moves to Phase II Clinical Trials
Phase I trial involving 47 patients identified maximum tolerated dose of 400 mg once daily
Low Incidence of Diabetic Ketoacidosis With Canagliflozin
Canagliflozin-treated patients with type 2 diabetes have low incidence of serious adverse DKA events
Atorvastatin/Ezetimibe Beats Atorvastatin After PCI
Combination therapy linked to greater coronary plaque regression in Japanese patients
Delays Noted in the Reporting of Serious Patient Harms to FDA
Analysis found roughly 10 percent of cases were filed after 15-day deadline passed
Progress Reported in Treatment of Marburg Virus
Researchers found infected monkeys were less likely to die with treatment
Oncologists Offer Strategies for Reducing Cost of Cancer Drugs
Suggest letting Medicare negotiate prices; back grassroots movement calling for change
Generic Meds Boost Survival in Some Early Breast Cancers
Researchers found benefit from aromatase inhibitors and bisphosphonates
Bevacizumab Safe, Stable for Multiple Dosing From Single Vial
No evidence of infection, inflammation when bevacizumab is stored at 4° Celsius for a week
Pharmacological Prophylaxis Doesn’t Cut VTE in Cirrhosis
Low rate of VTE in hospitalized patients with cirrhosis; unaffected by pharmacological prophylaxis
